As one of the original four Yamanaka factors identified for reprogramming iPSCs, KLF4 has been extensively studied in self‐renewal and lineage development of pluripotent stem cells and progenitor cells.[36] However, its role as an oncogenic factor or tumor suppressor in carcinogenesis and tumor progression remains context‐dependent and controversial. The gene discussed is KLF4; the disease is neoplasm.